This symposium is sponsored by Med Learning Group and supported by a grant from Amgen. This is not an official function/event of the American College of Rheumatology
Tuesday, November 10, 2026
5:30 PM – 5:45 PM ET Registration & Dinner
5:45 PM – 7:15 PM ET CE Symposium
Hyatt Regency Orlando
9801 International Drive
Orlando, FL 32819
Meeting Room: Regency Ballroom Q
PROGRAM FEATURES
- Interactive, case-based learning environment
- Quality Improvement Personalized Posters
PRESENTING FACULTY
 |
Arezou Khosroshahi, MD Professor of Medicine Rheumatology Division Director of Clinical Trials Emory University School of Medicine Atlanta, Georgia |
 |
John Stone, MD, MPH Professor of Medicine Harvard Medical School The Edward A. Fox Chair in Medicine Massachusetts General Hospital Executive Chairman The IgG4ward! Foundation Boston, Massachusetts |
PROGRAM OVERVIEW
This satellite CME symposium will provide an evidence-based review of the pathogenesis, clinical manifestations, diagnosis, and management of IgG4-related disease (IgG4-RD). Expert faculty will examine current diagnostic and classification criteria, discuss approaches to assessing disease activity to support timely and accurate diagnosis, and review clinical trial data evaluating current and emerging therapeutic options. The program is designed to translate the latest evidence into clinical practice, equipping healthcare professionals with practical strategies to optimize the evaluation and management of patients with IgG4-RD.
LEARNING OBJECTIVES
- Identify the pathogenesis and clinical manifestations of IgG4-RD
- Integrate diagnostic and classification criteria for IgG4-RD to assess disease activity to improve diagnostic accuracy
- Apply clinical trial data supporting current and emerging therapies to inform treatment strategies for patients with IgG4-RD
TARGET AUDIENCE
This activity is designed to meet the educational needs of rheumatologists and their associated advanced practice professionals.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
